OZEM vs. SURI ETF Comparison

Comparison of Roundhill GLP-1 & Weight Loss ETF (OZEM) to Simplify Exchange Traded Funds Simplify Propel Opportunities ETF (SURI)

OZEM

Roundhill GLP-1 & Weight Loss ETF

OZEM Description

OZEM targets the global weight management industry. The fund invests in companies involved in the development of GLP-1 and other weight loss drugs. GLP-1 agonists seek to aid in weight management by lowering blood sugar levels, reducing appetite, and promoting fullness. The portfolio consists of firms with GLP-1 and weight loss drugs that have been approved by or are currently undergoing Phase I, Phase II, and/or Phase III clinical trials of the US Food & Drug Administration (FDA), or any applicable food and drug regulator for non-US companies. The portfolio is constructed using a proprietary methodology, which selects companies with high levels of thematic relevance based on research of each companys public filings and disclosures. In addition, eligible securities must meet minimum market-cap and liquidity requirements. The actively managed fund, although rebalances portfolio weighting on at least a quarterly basis, may have a heavy concentration on a few names.

Grade (RS Rating)

Last Trade

$27.12

Average Daily Volume

74,426

Number of Holdings ^*

7

* may have additional holdings in another (foreign) market

SURI

Simplify Exchange Traded Funds Simplify Propel Opportunities ETF

SURI Description

The fund is an actively managed exchange-traded fund. The Sub-Adviser concentrates the fund's investments (i.e., invests more than 25% of its net assets) in the securities of issuers in the biotechnology, pharmaceuticals, healthcare technology, and life science tools and services industries. The Sub-Adviser employs an actively managed opportunistic multi-asset strategy that focuses on common stock, preferred stock, convertible bonds, structured notes, corporate notes and bonds, and ETFs that primarily invest in the preceding security types. The fund is non-diversified.

Grade (RS Rating)

Last Trade

$21.62

Average Daily Volume

2,896

Number of Holdings ^*

9

* may have additional holdings in another (foreign) market

Performance

Period	OZEM	SURI
30 Days	4.03%	-0.65%
60 Days		-1.46%
90 Days		-5.16%
12 Months		16.80%

0 Overlapping Holdings

	Symbol	Grade	Weight in OZEM	Weight in SURI	Overlap

OZEM Overweight 7 Positions Relative to SURI

	Symbol	Grade	Weight
	LLY	A	21.39%
	NVO	B	20.52%
	AMGN	B	4.2%
	ALT	F	3.97%
	TERN	C	3.32%
	VKTX	D	3.27%
	GPCR	F	3.14%

OZEM Underweight 9 Positions Relative to SURI

	Symbol	Grade	Weight
	PAGP	B	-25.08%
	APLT	C	-12.23%
	TCRX	F	-9.08%
	MDGL	C	-5.58%
	PHAT	C	-4.99%
	AKRO	C	-4.39%
	ATHA	C	-3.97%
	FULC	F	-3.7%
	RNA	C	-3.41%

OZEM: Top Represented Industries & Keywords

Industries: Biotechnology Drug Manufacturers - Major

Keywords: Obesity Biopharmaceutical Diabetes Medicine Pharmaceutical Products Anti Diabetic Drugs Glucagon Growth Hormone Hepatitis Inflammation Life Sciences Neuroscience Non Alcoholic Fatty Liver Disease Peptide Hormones Pulmonary Arterial Hypertension S&P 500 Steatohepatitis Wholesale Distributor Alcohol Alzheimer's Disease

SURI: Top Represented Industries & Keywords

Industries: Biotechnology Oil & Gas Midstream

Keywords: Biopharmaceutical Life Sciences Biotechnology Cancer Disease Disorders Medication Medicine Metabolic Disease Acid Alcohol Biopharmaceutical Products Brain Disorders Cardiomyopathy Cardiovascular And Metabolic Diseases Cardiovascular Disease Chemical Substances Cholesterol Clinical Trial Crude Oil